Literature DB >> 3926592

Vagal stimulation of human gastric bicarbonate secretion.

H Forssell, B Stenquist, L Olbe.   

Abstract

Gastric bicarbonate secretion in humans was determined in vivo by using a gastric perfusion-aspiration system. A computer calculated the bicarbonate concentration every 30 s throughout the experiment from measurements of the pH and PCO2 in the aspirate. The total bicarbonate concentration was calculated according to the formula of Henderson and Hasselbalch as the sum of free bicarbonate plus the CO2 that was formed during reaction of bicarbonate with hydrogen ions. In 16 subjects basal gastric bicarbonate secretion was 410 +/- 39 mumol/h (mean +/- SEM). After sham feeding using the chew and spit technique to achieve physiologic vagal activation, the gastric bicarbonate secretion rate increased to 692 +/- 67 mumol/h (p less than 0.001). This response of bicarbonate secretion rate to vagal stimulation was independent of the intragastric pH (range 2-7). In 6 subjects the sham-feeding response was almost abolished (88% inhibition) by the anticholinergic drug benzilonium bromide, however, it was unaffected by premedication with indomethacin. The findings demonstrate that the increase in gastric bicarbonate secretion during the cephalic phase of gastric secretion occurs parallel to the increase in acid secretion. It may therefore be regarded as a physiologic response to reinforce the protective mucus-bicarbonate barrier. The response to vagal stimulation seems to be mediated by a muscarinic transmitter and to be independent of intragastric pH and endogenous prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926592     DOI: 10.1016/0016-5085(85)90454-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Letters to the editor.

Authors:  S J Konturek
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

2.  Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.

Authors:  Malcolm Boyce; Steve Warrington; James Black
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

3.  Vagal control of gastric alkaline secretion.

Authors:  R W Stockbrügger
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

4.  Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress.

Authors:  Kurt Lenz; Robert Buder; Fritz Firlinger; Gerald Lohr; Martin Voglmayr
Journal:  Wien Klin Wochenschr       Date:  2014-11-20       Impact factor: 1.704

5.  Vagal cholinergic control of gastric alkaline secretion in normal subjects and duodenal ulcer patients.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; P Thor; J W Konturek; T Popiela; J Oleksy
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

6.  Duodenal mucosal bicarbonate secretion in man. Stimulation by acid and inhibition by the alpha 2-adrenoceptor agonist clonidine.

Authors:  L Knutson; G Flemström
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

7.  Neural influences on human esophageal and salivary alkali secretion.

Authors:  C M Brown; C F Snowdon; B Slee; L N Sandle; W D Rees
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Effect of proximal gastric vagotomy on calculated gastric HCO3- and nonparietal volume secretion in man. Studies during basal conditions and gastrin-17 infusion.

Authors:  M Feldman; A J Blair; C T Richardson
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism.

Authors:  S J Konturek; J Bilski; N Kwiecien; W Obtuløwicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

10.  Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans.

Authors:  A Mertz-Nielsen; J Hillingsø; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.